Cargando…

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy

INTRODUCTION: Outcome after postoperative radiochemotherapy (RT-CT) for patients with advanced head and neck squamous cell carcinomas (HNSCC) remains unsatisfactory, especially among those with HPV negative tumours. Therefore, new biomarkers are needed to further define subgroups for individualised...

Descripción completa

Detalles Bibliográficos
Autores principales:	De-Colle, Chiara, Mönnich, David, Welz, Stefan, Boeke, Simon, Sipos, Bence, Fend, Falko, Mauz, Paul-Stefan, Tinhofer, Inge, Budach, Volker, Jawad, Jehad Abu, Stuschke, Martin, Balermpas, Panagiotis, Rödel, Claus, Grosu, Anca-Ligia, Abdollahi, Amir, Debus, Jürgen, Bayer, Christine, Belka, Claus, Pigorsch, Steffi, Combs, Stephanie E., Lohaus, Fabian, Linge, Annett, Krause, Mechthild, Baumann, Michael, Zips, Daniel, Menegakis, Apostolos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833920/ https://www.ncbi.nlm.nih.gov/pubmed/29594214 http://dx.doi.org/10.1016/j.ctro.2017.06.004

Ejemplares similares

ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)
por: Stangl, Stefan, et al.
Publicado: (2017)

A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling
por: Leger, Stefan, et al.
Publicado: (2017)

DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
por: Tawk, Bouchra, et al.
Publicado: (2023)

Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
por: Niu, Minli, et al.
Publicado: (2021)

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
por: Patil, Shivaprasad, et al.
Publicado: (2022)

Radiotherapy and "new" drugs-new side effects?
por: Niyazi, Maximilian, et al.
Publicado: (2011)

Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
por: Leger, Stefan, et al.
Publicado: (2020)

Multitask Learning with Convolutional Neural Networks and Vision Transformers Can Improve Outcome Prediction for Head and Neck Cancer Patients
por: Starke, Sebastian, et al.
Publicado: (2023)

2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma
por: Starke, Sebastian, et al.
Publicado: (2020)

Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
por: Rabasco Meneghetti, Asier, et al.
Publicado: (2022)

Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients
por: Clasen, Kerstin, et al.
Publicado: (2021)

RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial
por: Martin, Daniel, et al.
Publicado: (2020)

Plasma sICAM-1 Correlates with Tumor Volume Before Primary Radiochemotherapy of Head and Neck Squamous Cell Carcinoma Patients
por: Clasen, Kerstin, et al.
Publicado: (2022)

Resolution of atelectasis during radiochemotherapy of lung cancer with serious implications for further treatment. A case report
por: Braun, Lore Helene, et al.
Publicado: (2017)

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
por: Linge, Annett, et al.
Publicado: (2019)

Surgery vs. radiotherapy in localized prostate cancer. Which is best?
por: Welz, Stefan, et al.
Publicado: (2008)

MR-Guided Radiotherapy for Head and Neck Cancer: Current Developments, Perspectives, and Challenges
por: Boeke, Simon, et al.
Publicado: (2021)

Estimation of secondary cancer projected risk after partial breast irradiation at the 1.5 T MR-linac
por: De-Colle, C., et al.
Publicado: (2022)

Analysis of pairwise correlations in multi-parametric PET/MR data for biological tumor characterization and treatment individualization strategies
por: Leibfarth, Sara, et al.
Publicado: (2016)

Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)
por: Combs, Stephanie E., et al.
Publicado: (2018)

Organ preservation in rectal cancer – Challenges and future strategies
por: Gani, C., et al.
Publicado: (2017)

Kein Vorteil für die lokale Kontrolle nach Dosiseskalation der Strahlentherapie bei Patienten mit Ösophaguskarzinom nach einer definitiven Radiochemotherapie: randomisierte Phase-III-Studie ARTDECO
por: Fokas, Emmanouil, et al.
Publicado: (2022)

Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2013)

Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2015)

Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer
por: Martin, Daniel, et al.
Publicado: (2017)

C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy
por: Martin, Daniel, et al.
Publicado: (2019)

Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions
por: Marini, Patrizia, et al.
Publicado: (2009)

Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: Perspective on technical and clinical validation
por: Thorwarth, Daniela, et al.
Publicado: (2020)

Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
por: Dellas, Kathrin, et al.
Publicado: (2013)

Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients
por: Hess, Julia, et al.
Publicado: (2022)

Ösophaguskarzinom: Prognoseverbesserung durch neoadjuvante Radiochemotherapie
por: Knippen, Stefan, et al.
Publicado: (2021)

Cell-line dependent effects of hypoxia prior to irradiation in squamous cell carcinoma lines
por: Hauth, Franziska, et al.
Publicado: (2017)

First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments
por: Combs, Stephanie E., et al.
Publicado: (2020)

Radiochemotherapy
Publicado: (1998)

Report on Late Toxicity in Head-and-Neck Tumor Patients with Long Term Survival after Radiochemotherapy
por: Buchberger, Anna Maria Stefanie, et al.
Publicado: (2021)

Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy
por: Schnöller, Leon Emanuel, et al.
Publicado: (2022)

Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy
por: Bütof, Rebecca, et al.
Publicado: (2017)

Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib
por: Hehlgans, Stephanie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b71vii584saes101mjtpicupd9